Firms

Verge HealthTech Fund

Verge HealthTech Fund

verge.fund

Verge HealthTech Fund is a Singapore-headquartered venture capital manager backing early-stage healthcare technology companies globally. It invests from pre-seed to Series A in healthcare AI and data analytics, diagnostics, connected medical devices, digital health platforms, digital therapeutics and healthcare software. Its partners and network combine scientific, clinical and operating backgrounds to support validation, regulatory planning and international commercialisation. Founded in 2018, Verge focuses on scalable technologies that improve healthcare access, affordability and efficiency, including underserved populations and low- and middle-income markets.

Founded
2018
Type
Venture capital

Funds1

  • Verge HealthTech Fund II—

    Global early-stage healthcare technology venture fund focused on affordable access to care, including AI and data, next-generation diagnostics, smart devices, digital therapeutics and healthcare software. GHIC publicly confirmed an investment through its Catalytic Health Investment Platform on July 24, 2025. This record dates that LP and fundraising update; it does not assert that the fund launched or reached final close on that day. The primary announcement does not disclose total fund size or the LP commitment amount.

Team

Operations and support

Albert BehrAdvisor
Aparna KrishnanVenture Partner
Brendan FarmerAdvisor
Carl Nicholas NgGeneral Partner
Ed DengCo-Founder and Operating Partner
Erika CheungAdvisor
Erki MölderManaging Partner
Ferdinand HuiVenture Partner
Gordon WatsonAdvisor
Jeremy LimJeremy LimAdvisor
John YoonAdvisor
Joice LuPortfolio Manager
Joseph MocanuCo-Founder and Managing Partner
Lincoln HengInvestment Analyst
Miguel LegardaInvestment Manager
Paul SupramaniamAdvisor
Riana ChuaFinance and Marketing Lead
Roberto PersivaleAdvisor
Rupam ShrivastavaAdvisor
Scarlett ChenManaging Partner
Shwen GweeAdvisor
Tyler ShultzVenture Partner

Co-investing

Investments